24/7 Pet Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. 2025 ICD-10-CM Diagnosis Code R97.20: Elevated prostate ...

    www.icd10data.com/ICD10CM/Codes/R00-R99/R97-R97/...

    ICD 10 code for Elevated prostate specific antigen [PSA]. Get free rules, notes, crosswalks, synonyms, history for ICD-10 code R97.20.

  3. R97.20 is a billable diagnosis code used to specify a medical diagnosis of elevated prostate specific antigen [psa]. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024.

  4. 2025 ICD-10-CM Diagnosis Code R97.2: Elevated prostate ...

    www.icd10data.com/ICD10CM/Codes/R00-R99/R97-R97/...

    ICD 10 code for Elevated prostate specific antigen [PSA]. Get free rules, notes, crosswalks, synonyms, history for ICD-10 code R97.2.

  5. Get crucial instructions for accurate ICD-10-CM R97.2 coding with all applicable Excludes 1 and Excludes 2 notes from the section level conveniently shown with each code.

  6. Coding Tips for Prostate Cancer Screening, Diagnosis, and ...

    aihc-assn.org/coding-tips-for-prostate-cancer...

    The ICD-10-CM code to use for annual screening services is Z12.5, Encounter for screening for malignant neoplasm of prostate. Codes in the Z12 category have a “Use additional code” instruction if there is family history of the disease.

  7. R97.20 is a valid billable ICD-10 diagnosis code for Elevated prostate specific antigen [PSA]. It is found in the 2024 version of the ICD-10 Clinical Modification (CM) and can be used in all HIPAA-covered transactions from Oct 01, 2023 - Sep 30, 2024 .

  8. 2024 ICD-10-CM Diagnosis Code R97.21: Rising PSA following ...

    www.icd10data.com/ICD10CM/Codes/R00-R99/R97-R97/...

    R97.21 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Short description: Rising PSA fol treatment for malignant neoplasm of prostate. The 2024 edition of ICD-10-CM R97.21 became effective on October 1, 2023.